<DOC>
	<DOCNO>NCT02657031</DOCNO>
	<brief_summary>This study compare efficacy low dose Ketamine versus Compazine control headache patient present Emergency Department .</brief_summary>
	<brief_title>The CHECK Trial : A Comparison Headache Treatment ED : Compazine Versus Ketamine</brief_title>
	<detailed_description>After enrollment , patient randomize either standard treatment arm receive prochlorperazine 10 mg IV along diphenhydramine 25 mg IV , OR study arm receive Ketamine 0.3 mg/kg along ondansetron 4 mg IV . The diphenhydramine ondansetron administer first , immediately afterward prochlorperazine Ketamine administer . The prochlorperazine Ketamine dilute saline total volume 5 mL , administer 2 minute . The diphenhydramine dilute saline 2 mL ( volume ondansetron ) . Both group also receive 500 mL normal saline bolus study medication administer . The ED pharmacist responsible preparing medication , use double-blind protocol . He record arm patient randomize . Only pharmacist access randomization record reveal randomization end study . Emergency provider instruct administer rescue medication least 30 minute . The electronic medical record order read `` randomized study medication '' ( Ketamine prochlorperazine ) `` randomize add-on medication '' ( ondansetron diphenhydramine ) .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Prochlorperazine</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Age 18 65 year Temperature &lt; 100.4Â° F Diastolic Blood Pressure &lt; 104 mm Hg Normal neurological exam mormal mental status Pregnant breastfeeding . Meningeal sign present Acute angle closure glaucoma suspect . Head trauma within previous two week Lumbar puncture within previous two week Thunderclap onset headache Weight 150 kg less 40 kg . Known allergy one study drug . History schizophrenia bipolar disorder . History intracranial hypertension . Is prisoner Patient decline informed consent NonEnglish speaking patient . Attending provider excludes patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Headache , Migraine</keyword>
</DOC>